Virpax Pharmaceuticals, Inc.
(NASDAQ : VRPX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -1.39%43.850.9%$1523.47m
ABBVAbbVie, Inc. -0.39%107.661.9%$991.05m
JNJJohnson & Johnson -0.36%164.620.7%$987.18m
MRKMerck & Co., Inc. -0.50%71.610.7%$796.28m
LLYEli Lilly & Co. -0.47%229.961.1%$594.20m
BMYBristol-Myers Squibb Co. 0.03%61.251.0%$551.71m
AZNAstraZeneca Plc -1.84%55.561.0%$261.07m
NVSNovartis AG -1.08%83.470.2%$168.99m
SNYSanofi 0.39%48.380.2%$137.69m
GSKGlaxoSmithKline Plc -0.44%38.940.2%$122.91m
RPRXRoyalty Pharma Plc 0.31%38.500.1%$119.08m
NVONovo Nordisk A/S -0.94%101.420.1%$109.34m
VTRSViatris, Inc. -0.88%13.570.0%$109.22m
RGENRepligen Corp. 2.34%306.906.8%$102.98m
APLSApellis Pharmaceuticals, Inc. 0.62%34.210.0%$96.93m

Company Profile

Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.